-
Something wrong with this record ?
Nestin as a marker of cancer stem cells
J. Neradil, R. Veselska,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NT13443
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2014
PubMed Central
from 2003
Europe PubMed Central
from 2012
ProQuest Central
from 1988-01-01
Open Access Digital Library
from 1997-01-01
Open Access Digital Library
from 2014-01-01
Medline Complete (EBSCOhost)
from 2005-01-01
Wiley-Blackwell Open Access Titles
from 2003
ROAD: Directory of Open Access Scholarly Resources
from 1998
PubMed
25940879
DOI
10.1111/cas.12691
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Biomarkers, Tumor metabolism MeSH
- Neoplastic Stem Cells metabolism MeSH
- Neoplasms metabolism pathology MeSH
- Nestin metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The crucial role of cancer stem cells (CSCs) in the pathology of malignant diseases has been extensively studied during the last decade. Nestin, a class VI intermediate filament protein, was originally detected in neural stem cells during development. Its expression has also been reported in different tissues under various pathological conditions. Specifically, nestin has been shown to be expressed in transformed cells of various human malignancies, and a correlation between its expression and the clinical course of some diseases has been proved. Furthermore, the coexpression of nestin with other stem cell markers was described as a CSC phenotype that was subsequently verified using tumorigenicity assays. The primary aim of this review is to summarize the recent findings regarding nestin expression in CSCs, its possible role in CSC phenotypes, particularly with respect to capacity for self-renewal, and its utility as a putative marker of CSCs.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000150
- 003
- CZ-PrNML
- 005
- 20200121084320.0
- 007
- ta
- 008
- 160108s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/cas.12691 $2 doi
- 035 __
- $a (PubMed)25940879
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Neradil, Jakub $u Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. $7 xx0079539
- 245 10
- $a Nestin as a marker of cancer stem cells / $c J. Neradil, R. Veselska,
- 520 9_
- $a The crucial role of cancer stem cells (CSCs) in the pathology of malignant diseases has been extensively studied during the last decade. Nestin, a class VI intermediate filament protein, was originally detected in neural stem cells during development. Its expression has also been reported in different tissues under various pathological conditions. Specifically, nestin has been shown to be expressed in transformed cells of various human malignancies, and a correlation between its expression and the clinical course of some diseases has been proved. Furthermore, the coexpression of nestin with other stem cell markers was described as a CSC phenotype that was subsequently verified using tumorigenicity assays. The primary aim of this review is to summarize the recent findings regarding nestin expression in CSCs, its possible role in CSC phenotypes, particularly with respect to capacity for self-renewal, and its utility as a putative marker of CSCs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x metabolismus $x patologie $7 D009369
- 650 _2
- $a nádorové kmenové buňky $x metabolismus $7 D014411
- 650 _2
- $a nestin $x metabolismus $7 D064231
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Veselská, Renata, $u Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic. Department of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech Republic. $d 1968- $7 mzk2003196540
- 773 0_
- $w MED00007527 $t Cancer science $x 1349-7006 $g Roč. 106, č. 7 (2015), s. 803-811
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25940879 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20200121084657 $b ABA008
- 999 __
- $a ok $b bmc $g 1102431 $s 924356
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 106 $c 7 $d 803-811 $e 20150526 $i 1349-7006 $m Cancer science $n Cancer Sci $x MED00007527
- GRA __
- $a NT13443 $p MZ0
- LZP __
- $a Pubmed-20160108